Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair shedding during Wegovy treatment is real, but it is rarely permanent. Clinically, the pattern most commonly reported is telogen effluvium, a temporary shift in the hair growth cycle triggered by rapid weight loss rather than by semaglutide itself. It typically begins two to four months into treatment and resolves on its own over a similar timeframe. Understanding why it happens is the first step to preventing it from becoming worse. As a prescription-only medicine, Wegovy is supplied only after a clinical assessment, and any concerns about side effects, including hair loss on Wegovy, are part of the conversation a prescriber should have with you before and during treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Telogen effluvium happens when a physical stressor pushes a larger-than-usual proportion of hair follicles into the resting (telogen) phase simultaneously. The stressor here is the calorie deficit and the speed of weight loss, not a toxicity effect of semaglutide. Follicles are alive; they just pause. When the stressor lifts and nutritional status stabilises, they re-enter the growth phase and shedding slows.
Knowing this matters practically. It means your goal is to moderate the metabolic stress on the body, not to stop treatment. Our overview of Wegovy side effects puts hair changes in context alongside the more common gastrointestinal effects, and it is worth reading both together. The NHS semaglutide medicines page lists hair loss among the less common reported effects, which confirms it is on clinicians' radar without categorising it as a serious harm.
One practical point: the two-to-four month lag between the trigger and the visible shedding can be confusing. People often blame a recent dose increase when the real cause was a nutritional dip weeks earlier. Keeping a simple food diary through the early months helps you and your prescriber trace patterns accurately rather than guessing.
Appetite suppression is the point of treatment. But eating less means consuming fewer building blocks for hair protein, which is almost entirely keratin. The three most useful actions are prioritising protein at every meal, checking for deficiencies through a GP or private blood test, and supplementing only where a real gap is confirmed.
Protein is the headline: aim for a meaningful portion of a high-quality source, such as eggs, fish, chicken, Greek yoghurt or pulses, at each meal. Precise targets should be discussed with your prescriber or a dietitian, but the general principle is to resist letting protein slip as overall intake falls. Iron-deficiency anaemia is a common independent cause of diffuse hair loss in women of reproductive age; if you are losing hair and have heavy periods, iron levels are worth checking explicitly. Zinc and vitamin D deficiency also appear in the literature as contributors.
The temptation to load up on biotin supplements is understandable, but evidence for biotin supplementation in people who are not already deficient is thin. Spending the money on a blood panel first is more useful. Our detailed prevention guide covers specific nutrients and practical meal ideas for people in earlier treatment phases.
Follicles under metabolic stress are more susceptible to mechanical damage. A few habit changes can reduce unnecessary breakage without requiring a full overhaul of your routine. Use a wide-toothed comb on wet hair rather than a brush. Reduce heat styling frequency during the months when shedding tends to peak. Tight ponytails and extensions add traction stress that telogen-phase follicles handle poorly.
Scalp health also matters. A clean, well-circulated scalp environment is supportive; products that block follicles or cause irritation are not. Some people find scalp massage helpful for circulation, and it costs nothing except a few minutes before the kettle boils in the morning.
Distinguishing normal telogen effluvium from something else is important. Normal shedding is diffuse, meaning spread evenly rather than appearing in patches, and the hair that falls has a white root bulb rather than a snapped shaft. Patchy loss, scalp inflammation, loss of eyebrows or lashes, or shedding that continues beyond six months without any slowing all warrant a GP or dermatologist review. The connection between Wegovy and hair loss patterns is explored in more detail if you want to compare what you are seeing with what the evidence describes.
For most people, hair shedding on Wegovy is manageable and self-limiting. There are situations, though, where a clinician should be involved promptly rather than waiting to see how things settle.
Get medical advice if: shedding is severe enough to cause visible scalp show-through; it begins suddenly and heavily rather than gradually; it is accompanied by scalp pain, redness or scaling; or your hair has not begun to recover six months after starting treatment or after the weight-loss rate has slowed. A GP can arrange blood tests to rule out thyroid dysfunction, anaemia and nutritional deficiencies, all of which are treatable and all of which independently cause hair loss.
Any side effect you believe is linked to Wegovy can be reported through the MHRA's Yellow Card reporting system. This is not only for serious events; pattern data from everyday reports shapes how regulators update prescribing guidance over time, so your experience contributes to a wider picture.
At nume, our prescribers discuss both the expected side-effect profile and individual risk factors as part of every consultation, not as a formality at the end. If you have concerns about hair loss or any other effect, speaking to our prescribers as part of your free consultation is the place to start. You can also read about the full Wegovy treatment overview or explore managing nausea on Wegovy alongside this page if you are weighing up multiple side effects at once.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.